UnitedHealth Group Inc. (NYSE:UNH) has been given a consensus rating of “Buy” by the twenty-six brokerages that are currently covering the company. One investment analyst has rated the stock with a hold rating, twenty-three have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $154.61.
UNH has been the subject of a number of recent research reports. Wedbush reissued an “outperform” rating and set a $165.00 price objective on shares of UnitedHealth Group in a report on Tuesday, July 19th. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a report on Friday, July 22nd. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 21st. Citigroup Inc. boosted their price objective on UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Credit Suisse Group AG reissued a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a report on Wednesday, June 29th.
In related news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.65% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Van Hulzen Asset Management LLC bought a new position in shares of UnitedHealth Group during the second quarter worth about $104,000. Archford Capital Strategies LLC boosted its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares during the period. MCF Advisors LLC boosted its position in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares during the period. Hanson McClain Inc. boosted its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares during the period. Finally, Howe & Rusling Inc. boosted its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares during the period. 85.78% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group (NYSE:UNH) traded up 0.56% during mid-day trading on Wednesday, reaching $138.24. The company had a trading volume of 1,530,723 shares. UnitedHealth Group has a one year low of $107.51 and a one year high of $144.48. The company’s 50-day moving average is $139.00 and its 200-day moving average is $135.11. The stock has a market capitalization of $131.66 billion, a PE ratio of 21.63 and a beta of 0.57.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.07. The firm earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. Equities research analysts anticipate that UnitedHealth Group will post $7.92 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.82%. UnitedHealth Group’s dividend payout ratio is presently 39.12%.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.